Statistics on Biotechnology Use  
Results by sector of operation
Sector Companies. Results in biotechnology for main variables and branches of activity 
Unidades: specified in variables

,Total Companies,Services,Industry and Construction,Agriculture,
No. of companies carrying out R&D in Biotechnology,1.133,740,313,80,
%Companies according to biotechnology used: Genetic code,32,39,16,28,
%Companies according to biotechnology used: Functional units,41,44,37,27,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,27,33,13,27,
%Companies according to biotechnology used: Bioprocesses,48,39,73,37,
%Companies according to biotechnology used: Sub-cellular organisms,8,11,4,1,
%Companies according to biotechnology used: Bio-computing,21,29,7,8,
%Companies according to biotechnology used: Nanobiotechnology,14,18,9,2,
%Companies according to biotechnology used: Other,13,13,11,22,
Companies in which biotechnology activities are: Main and/or exclusive,564,485,70,8,
Companies in which biotechnology activities are: A secondary line of business,212,129,68,15,
Companies in which biotechnology activities are: A tool necessary for production,358,126,174,57,
%Company by field(s) of ultimate application of biotechnology use: Human Health,50,64,28,2,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,19,19,14,35,
%Company by field(s) of ultimate application of biotechnology use: Food products,29,22,48,28,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,21,19,18,54,
%Company by field(s) of ultimate application of biotechnology use: Environment,13,13,13,7,
%Company by field(s) of ultimate application of biotechnology use: Industry,13,15,14,1,
Personnel in R&D in biotechnology (no. of persons),10.706,7.082,2.911,713,
Personnel in R&D in biotechnology (no. of persons): Researchers,6.227,4.618,1.376,234,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,4.479,2.464,1.536,479,
Personnel in R&D in biotechnology (no. of persons): women,5.795,4.017,1.487,291,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,3.269,2.462,708,99,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,2.527,1.555,780,192,
Personnel in R&D in biotechnology (FTE),7.716,4,5.271,6,1.994,1,450,7,
Personnel in R&D in biotechnology (FTE): Researchers,4.603,1,3.428,2,1.011,8,163,1,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,3.113,3,1.843,4,982,3,287,6,
Personnel in R&D in biotechnology (FTE): women,4.292,9,2.988,8,1.092,6,211,6,
Personnel in R&D in biotechnology (FTE): (women) Researchers,2.446,4,1.824,2,546,4,75,8,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,1.846,5,1.164,5,546,2,135,8,
Internal expenditure on R&D (thousands of euros),616.053,419.246,169.526,27.280,
1) By nature of the expense: Current expenses,574.245,386.169,162.807,25.269,
1.1) Remuneration to researchers,221.741,154.058,59.929,7.754,
1.2) Remuneration to technicians and assistants,102.464,54.152,40.900,7.411,
1.3) Other current expenses,250.041,177.959,61.978,10.103,
2) By nature of the expense: Capital expenses,41.808,33.077,6.719,2.012,
2.1) Land and buildings,5.359,3.804,1.179,376,
2.2) Equipment and instruments,29.489,22.799,5.142,1.548,
2.3) Acquisition of specific R&D software,2.306,2.155,150,0,
2.4) Otros productos de propiedad intelectual específicos para I+D,4.654,4.320,247,87,
1) By origin of the funds: National funds,511.960,353.937,132.650,25.373,
1.1) Own funds,382.335,236.135,122.657,23.543,
1.2) From companies,45.024,42.403,2.620,.,
1.3) Public Administration funds,72.387,63.184,7.373,1.830,
1.4) From Universities,363,363,.,.,
1.5) From non profit private institutions,11.851,11.851,.,.,
1) By origin of the funds: Foreign funds,104.093,65.309,36.877,1.907,
2.1) From EU programmes,21.825,20.023,1.726,77,
2.2) Other foreign funds,82.269,45.287,35.151,1.831,
Purchase of R&D services in biotechnology (thousands of euros),144.342,80.058,62.756,1.527,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,70.458,29.338,40.495,625,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,73.885,50.721,22.261,902,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,48,57,31,34,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,13,13,12,19,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,15,16,12,20,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,12,13,12,7,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,16,18,11,9,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels,16,19,11,7,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,16,17,12,12,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,36,39,33,21,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,49,54,38,38,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,18,19,15,18,
% Companies that have requested biotechnology patents in Biotechnology,16,20,9,5,
Number of patents requested,633,497,87,49,
% Companies with income of an international origin related to biotechnological activities,24,26,6,22,3,6,7,
% Turnover representing income of an international origin related to biotechnological activities,1,4,4,2,1,2,0,7,
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU,57,3,35,2,64,8,44,6,
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries,42,7,64,8,35,2,55,4,
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services,82,3,92,78,8,97,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,16,5,4,5,20,7,3,
% Income of an international origin related with activities according to the classification: Operating source abroad,1,3,2,0,3,.,
% Income of an international origin related with activities according to the classification: Other,0,3,0,4,0,3,.,
Notas:

.
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute